James H. Wikel
Technik-/Wissenschafts-/F&E-Leiter bei Apexian Pharmaceuticals, Inc.
Profil
James H.
Wikel is currently the Head of Research & Development at Apexian Pharmaceuticals, Inc. He was previously a Principal at Eli Lilly & Co. from 1971 to 2004 and the Chief Technology Officer at Coalesix, Inc. He received his undergraduate and graduate degrees from Marshall University.
Aktive Positionen von James H. Wikel
| Unternehmen | Position | Beginn |
|---|---|---|
Apexian Pharmaceuticals, Inc.
 Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von James H. Wikel
| Unternehmen | Position | Ende |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| Coalesix, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von James H. Wikel
| Marshall University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Coalesix, Inc. | |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Health Technology |
